NeoGenomics is a trusted leader in developing state-of-the-art histopathology testing solutions to empower our pharmaceutical partners. With over a decade of experience, we consistently provide high-quality, reliable results regardless of project scope or intended use, adhering to the most rigorous industry standards.
Comprehensive Histopathology Capabilities
We offer end-to-end workflow from tissue processing, embedding, and microtomy to a wide range of downstream modalities designed to streamline your development timeline.
| ✓ 400+ validated biomarkers to support clinical trial needs | ✓ Advanced image analysis for qualitative and quantitative scoring |
| ✓ Sub-specialized pathology expertise for precise evaluations and reporting | ✓ Extensive experience in prospecting tests needs and companion diagnostics (CDx) development |
| ✓ Custom biomarker solutions for tailored development and validation of novel and emerging biomarkers |
Partner with us to accelerate biomarker detection, disease classification, patient cohort identification, prognosis assessment, therapeutic target validation, and tumor microenvironment characterization.
IHC/ISH services
Spatial services
Advanced pathology and image analysis services
Expertise You Can Trust. Resources You Can Act On.
Explore our webinars, white papers, and other valuable resources